The midbrain to pons ratio

Objectives: MRI-based measurements used to diagnose progressive supranuclear palsy (PSP) typically lack pathologic verification and are not easy to use routinely. We aimed to develop in histologically proven disease a simple measure of the midbrain and pons on sagittal MRI to identify PSP. Methods: Measurements of the midbrain and pontine base on midsagittal T1-weighted MRI were performed in confirmed PSP (n = 12), Parkinson disease (n = 2), and multiple system atrophy (MSA) (n = 7), and in controls (n = 8). Using receiver operating characteristic curve analysis, cutoff values were applied to a clinically diagnosed cohort of 62 subjects that included PSP (n = 21), Parkinson disease (n = 10), MSA (n = 10), and controls (n = 21). Results: The mean midbrain measurement of 8.1 mm was reduced in PSP (p < 0.001) with reduction in the midbrain to pons ratio (PSP smaller than MSA; p < 0.001). In controls, the mean midbrain ratio was approximately two-thirds of the pontine base, in PSP it was <52%, and in MSA the ratio was greater than two-thirds. A midbrain measurement of <9.35 mm and ratio of 0.52 had 100% specificity for PSP. In the clinically defined group, 19 of 21 PSP cases (90.5%) had a midbrain measurement of <9.35 mm. Conclusions: We have developed a simple and reliable measurement in pathologically confirmed disease based on the topography of atrophy in PSP with high sensitivity and specificity that may be a useful tool in the clinic.

[1]  D. Dickson,et al.  MR imaging of brainstem atrophy in progressive supranuclear palsy , 2007, Journal of Neurology.

[2]  I Litvan,et al.  Consensus statement on the diagnosis of multiple system atrophy , 1998, Journal of the Neurological Sciences.

[3]  D. Royall,et al.  The FAB: A frontal assessment battery at bedside , 2001, Neurology.

[4]  W. Gibb,et al.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[5]  K. Arai,et al.  Study of the rostral midbrain atrophy in progressive supranuclear palsy , 2003, Journal of the Neurological Sciences.

[6]  N. Hashimoto,et al.  Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy , 2000, Journal of Neural Transmission.

[7]  A. Righini,et al.  MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. , 2004, AJNR. American journal of neuroradiology.

[8]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .

[9]  Johannes Dichgans,et al.  Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration , 2004, NeuroImage.

[10]  L Solymosi,et al.  Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. , 2001, Archives of neurology.

[11]  L. Golbe,et al.  A clinical rating scale for progressive supranuclear palsy. , 2007, Brain : a journal of neurology.

[12]  Yoav Ben-Shlomo,et al.  The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. , 2002, Brain : a journal of neurology.

[13]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[14]  M. Hallett,et al.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.

[15]  Francesco Fera,et al.  MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. , 2008, Radiology.

[16]  S. Fahn Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[17]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[18]  Sid Gilman,et al.  Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS) , 2004, Movement disorders : official journal of the Movement Disorder Society.

[19]  A. Kastrup,et al.  Penguins and hummingbirds: Midbrain atrophy in progressive supranuclear palsy , 2006, Neurology.

[20]  Z. Wszolek,et al.  New and reliable MRI diagnosis for progressive supranuclear palsy , 2006, Neurology.

[21]  F. Tison,et al.  Oral zolmitriptan is effective in the acute treatment of cluster headache , 2000, Neurology.

[22]  Nick C Fox,et al.  Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy , 2012, Movement disorders : official journal of the Movement Disorder Society.